MedTrace Logo

An Observational Clinical Study of the T3 Dental Implant System

NCT05062863 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 139

Last updated 2026-05-06

No results posted yet for this study

Summary

This will be a prospective, observational study where all implants will be placed in either the maxilla or mandible and loaded immediately (within 48 hours), early (within 6-8 weeks) or delayed (\> 8 weeks) with a provisional or definitive prosthesis. The implants will be evaluated yearly for 2 years.

Conditions

  • Edentulous Jaw

Interventions

DEVICE

T3 dental implant system

This clinical study will evaluate patients being treated with the T3 dental implant to confirm its safety and performance (effect of treatment of edentulism). The patients treated will experience a benefit from treatment of edentulism with the T3 dental implant system. The patients will be followed prospectively from the time of exposure (dental implant placement surgery) to outcome (implant survival at 2 years).

Sponsors & Collaborators

  • ZimVie

    lead INDUSTRY

Principal Investigators

  • Hai Bo Wen, PhD · ZimVie

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-20
Primary Completion
2025-10-30
Completion
2026-02-28
FDA Device
Yes

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05062863 on ClinicalTrials.gov